Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An outbreak of influenza A(H1N1)pdm09 antigenic variants exhibiting cross-resistance to oseltamivir and peramivir in an elementary school in Japan, September 2024.
Takashita E, Shimizu K, Usuku S, Senda R, Okubo I, Morita H, Nagata S, Fujisaki S, Miura H, Kishida N, Nakamura K, Shirakura M, Ichikawa M, Matsuzaki Y, Watanabe S, Takahashi Y, Hasegawa H. Takashita E, et al. Euro Surveill. 2024 Dec;29(50):2400786. doi: 10.2807/1560-7917.ES.2024.29.50.2400786. Euro Surveill. 2024. PMID: 39668762 Free PMC article.
Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.
Takashita E, Kiso M, Fujisaki S, Yokoyama M, Nakamura K, Shirakura M, Sato H, Odagiri T, Kawaoka Y, Tashiro M. Takashita E, et al. Antimicrob Agents Chemother. 2015 May;59(5):2607-17. doi: 10.1128/AAC.04836-14. Epub 2015 Feb 17. Antimicrob Agents Chemother. 2015. PMID: 25691635 Free PMC article.
Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Kuwahara T, Shimazu Y, Shimomura T, Watanabe S, Odagiri T; Influenza Virus Surveillance Group of Japan. Takashita E, et al. Euro Surveill. 2016 Jun 16;21(24). doi: 10.2807/1560-7917.ES.2016.21.24.30258. Euro Surveill. 2016. PMID: 27336226 Free article.
Characterization of influenza A(H1N1)pdm09 viruses isolated from Nepalese and Indian outbreak patients in early 2015.
Nakamura K, Shirakura M, Fujisaki S, Kishida N, Burke DF, Smith DJ, Kuwahara T, Takashita E, Takayama I, Nakauchi M, Chadha M, Potdar V, Bhushan A, Upadhyay BP, Shakya G, Odagiri T, Kageyama T, Watanabe S. Nakamura K, et al. Among authors: takashita e. Influenza Other Respir Viruses. 2017 Sep;11(5):399-403. doi: 10.1111/irv.12469. Epub 2017 Aug 9. Influenza Other Respir Viruses. 2017. PMID: 28792671 Free PMC article.
Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018.
Takashita E, Kawakami C, Morita H, Ogawa R, Fujisaki S, Shirakura M, Miura H, Nakamura K, Kishida N, Kuwahara T, Mitamura K, Abe T, Ichikawa M, Yamazaki M, Watanabe S, Odagiri T; Influenza Virus Surveillance Group of Japan. Takashita E, et al. Euro Surveill. 2019 Jan;24(3):1800698. doi: 10.2807/1560-7917.ES.2019.24.3.1800698. Euro Surveill. 2019. PMID: 30670142 Free PMC article.
Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019.
Takashita E, Kawakami C, Ogawa R, Morita H, Fujisaki S, Shirakura M, Miura H, Nakamura K, Kishida N, Kuwahara T, Ota A, Togashi H, Saito A, Mitamura K, Abe T, Ichikawa M, Yamazaki M, Watanabe S, Odagiri T. Takashita E, et al. Euro Surveill. 2019 Mar;24(12):1900170. doi: 10.2807/1560-7917.ES.2019.24.12.1900170. Euro Surveill. 2019. PMID: 30914078 Free PMC article.
Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment.
Takashita E, Abe T, Morita H, Nagata S, Fujisaki S, Miura H, Shirakura M, Kishida N, Nakamura K, Kuwahara T, Mitamura K, Ichikawa M, Yamazaki M, Watanabe S, Hasegawa H; Influenza Virus Surveillance Group of Japan. Takashita E, et al. Antiviral Res. 2020 Aug;180:104828. doi: 10.1016/j.antiviral.2020.104828. Epub 2020 Jun 20. Antiviral Res. 2020. PMID: 32574689 Free article.
Antiviral Susceptibilities of Avian Influenza A(H5), A(H7), and A(H9) Viruses Isolated in Japan.
Takashita E, Morita H, Nagata S, Shirakura M, Fujisaki S, Miura H, Takayama I, Arita T, Suzuki Y, Yamaoka M, Tanikawa T, Tsunekuni R, Mine J, Sakuma S, Uchida Y, Shibata A, Iwanaka M, Kishida N, Nakamura K, Kageyama T, Watanabe S, Hasegawa H; Influenza Virus Surveillance Group of Japan. Takashita E, et al. Jpn J Infect Dis. 2022 Jul 22;75(4):398-402. doi: 10.7883/yoken.JJID.2021.751. Epub 2021 Dec 28. Jpn J Infect Dis. 2022. PMID: 34980710 Free article.
A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023.
Takashita E, Fujisaki S, Morita H, Nagata S, Miura H, Matsuura Y, Yamamoto S, Chiba S, Inoue Y, Minami I, Yoshikawa S, Yamazaki S, Kishida N, Nakamura K, Shirakura M, Watanabe S, Hasegawa H. Takashita E, et al. Euro Surveill. 2023 Sep;28(39):2300501. doi: 10.2807/1560-7917.ES.2023.28.39.2300501. Euro Surveill. 2023. PMID: 37768560 Free PMC article.
98 results